Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Malcovati L, Della Porta MG, Pietra D, Boveri E, Pellagatti A, Gallì A, Travaglino E, Brisci A, Rumi E, Passamonti F, Invernizzi R, Cremonesi L, Boultwood J, Wainscoat JS, Hellström-Lindberg E, Cazzola M.

Blood. 2009 Oct 22;114(17):3538-45. doi: 10.1182/blood-2009-05-222331. Epub 2009 Aug 19.

2.

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.

Raya JM, Arenillas L, Domingo A, Bellosillo B, Gutiérrez G, Luño E, Piñán MA, Barbón M, Pérez-Sirvent ML, Muruzábal MJ, Yánez L, García L, Lemes A, Navarro JT, Elosegi A, Cortés MA, Villegas A, Durán MA, Ardanaz M, Florensa L; Grupo Español de Citología Hematológica, Working Group into the Asociación Española de Hematología y Hemoterapia.

Int J Hematol. 2008 Nov;88(4):387-95. doi: 10.1007/s12185-008-0169-1. Epub 2008 Sep 27.

PMID:
18820995
3.

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Schmitt-Graeff AH, Teo SS, Olschewski M, Schaub F, Haxelmans S, Kirn A, Reinecke P, Germing U, Skoda RC.

Haematologica. 2008 Jan;93(1):34-40. doi: 10.3324/haematol.11581.

5.

Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.

Tatic A, Vasilică M, Coliţă A, Vasilache D, Dobrea C, Jardan C, Găman AM, Crişan AM, Coliţă D, Coriu D.

Rom J Morphol Embryol. 2013;54(4):1177-82.

6.

Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors.

Suzuki H, Asano H, Ohashi H, Kinoshita T, Murate T, Saito H, Hotta T.

Leukemia. 1999 Jan;13(1):130-4.

PMID:
10049048
7.

Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?

Wardrop D, Steensma DP.

Br J Haematol. 2009 Mar;144(6):809-17. doi: 10.1111/j.1365-2141.2008.07526.x. Epub 2008 Dec 11. Review.

PMID:
19120370
8.

Refractory anemia with ring sideroblasts and RARS with thrombocytosis.

Patnaik MM, Tefferi A.

Am J Hematol. 2015 Jun;90(6):549-59. doi: 10.1002/ajh.24038. Review.

9.

Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings.

Gurevich I, Luthra R, Konoplev SN, Yin CC, Medeiros LJ, Lin P.

Am J Clin Pathol. 2011 Mar;135(3):398-403. doi: 10.1309/AJCPT0B6VEQPRCOA.

PMID:
21350094
10.

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation.

Szpurka H, Tiu R, Murugesan G, Aboudola S, Hsi ED, Theil KS, Sekeres MA, Maciejewski JP.

Blood. 2006 Oct 1;108(7):2173-81. Epub 2006 Jun 1.

11.
12.

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.

Broseus J, Florensa L, Zipperer E, Schnittger S, Malcovati L, Richebourg S, Lippert E, Cermak J, Evans J, Mounier M, Raya JM, Bailly F, Gattermann N, Haferlach T, Garand R, Allou K, Besses C, Germing U, Haferlach C, Travaglino E, Luno E, Pinan MA, Arenillas L, Rozman M, Perez Sirvent ML, Favre B, Guy J, Alonso E, Ahwij N, Jerez A, Hermouet S, Maynadié M, Cazzola M, Girodon F.

Haematologica. 2012 Jul;97(7):1036-41. doi: 10.3324/haematol.2011.053918. Epub 2012 Apr 24.

13.

[Clinical and biological features in refractory anemia with ringed sideroblasts with fluctuant platelet counts].

Ji O, Shen Q, Lin L, Zhang YC, Ji JM, Wu Y, Chen JY, Zhu GR, Kong XT, Xia W, Jiang PJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1036-41. Chinese.

PMID:
20723324
14.

[Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies].

Gérard J, Dubois-Galopin F, Gardembas-Pain M, Defaux JB, Schmidt-Tanguy A, Godon A, Geneviève F, Blanchet O, Ifrah N, Zandecki M.

Ann Biol Clin (Paris). 2005 Nov-Dec;63(6):653-9. Review. French.

15.

Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.

Patnaik MM, Lasho TL, Finke CM, Hanson CA, King RL, Ketterling RP, Gangat N, Tefferi A.

Am J Hematol. 2016 May;91(5):492-8. doi: 10.1002/ajh.24332. Epub 2016 Apr 4.

16.

Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation.

Lu CM, Zhou L, Wang E, Feng S, Sebastian S, Behler C.

Leuk Lymphoma. 2011 Dec;52(12):2405-7. doi: 10.3109/10428194.2011.597907. Epub 2011 Aug 1. No abstract available.

PMID:
21806348
17.

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.

Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H, Littlewood TJ, Malcovati L, Della Porta MG, Jädersten M, Killick S, Giagounidis A, Bowen D, Hellström-Lindberg E, Cazzola M, Wainscoat JS.

PLoS One. 2008 Apr 9;3(4):e1970. doi: 10.1371/journal.pone.0001970.

18.

MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count.

Steensma DP, Caudill JS, Pardanani A, McClure RF, Lasho TL, Tefferi A.

Haematologica. 2006 Dec;91(12 Suppl):ECR57.

19.

Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.

Ziarkiewicz M, Dwilewicz-Trojaczek J, Pastwińska A, Chmarzyńska E, Paszkowska-Kowalewska M, Koperski Ł, Jędrzejczak WW, Ziarkiewicz-Wróblewska B.

Pol J Pathol. 2010;61(2):105-9.

20.

Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.

Huls G, Mulder AB, Rosati S, van de Loosdrecht AA, Vellenga E, de Wolf JT.

Blood. 2010 Jul 15;116(2):180-2. doi: 10.1182/blood-2010-01-263087. Epub 2010 Mar 1.

Supplemental Content

Support Center